AKT1 and metabolic dysfunction-associated steatotic liver disease: CPT reversed liver injury in mice with NAFLD, reduced serum and liver lipid levels, and significantly inhibited the secretion of pro-inflammatory cytokines. Moreover, it significantly increased the expression of phosphorylated proteins of PI3K, Akt, and GSK3β.